Register now to our Newsletter

TransCure is proud to serve researchers in the field by providing suitable HIV mouse disease models.

Find more about how TransCure improves immuno-oncology research with its humanized mouse model.

TransCure bioServices improves animal health and wellbeing by using microchip-based identification system in order to deliver the best quality data to the customers.

TransCure bioServices shares with you its major achievements in 2018 and its objectives 2019.

Targovax demonstrates the “Synergistic effect of oncolytic virus combined with anti-PD-1 against Melanoma”. TransCure’s hu-mouse are the preferred in vivo models for combination therapy evaluation.

Besides being present at I4ID event, Sébastien Tabruyn, our CSO, will give a pitch for answering one question : “How humanized mice models helps to evaluate immunotherapy for infectious Diseases?”

TransCure team has just acquired a second AttuneTM NxT Flow Cytometer. With this new cytometer, the scientific team will be able to carry out more accurate studies, analyze more sample types and expand its capabilities.

Patrick Nef, CEO at TransCure reacts to Jim Allison and Tasuku Honjo’s awards for their research on immunotherapy.

TransCure bioServices (TCS) hired Antoine POSKIN, Veterinarian, PhD to manage the animal Facilities and get the AAALAC accreditation   AAALAC accreditation is a process that demonstrates the use of high standards and state of the art facility (equipment,...

Find more about TransCure humanized mice models which makes it possible to test novel anti-HIV treatments on infected animal models with a fully functional human immune system!